Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection

Table 2 Distribution of 14 high-risk HPV types in age groups

HPV type	30–39 y (n = 5219)		40–49 y (n = 13,370)		50–59 y (n = 16,940)		60–70 y (n = 5164)		All ages (n = 40,693)
HPV type	Positive no. (%)	95% CI	Positive no. (%)	95% CI	Positive no. (%)	95% CI	Positive no. (%)	95% CI	Positive no. (%)	95% CI
16	55 (1.1)	0.8–1.3	127 (1.0)	0.8–1.1	212 (1.3)	1.1–1.4	89 (1.7)	1.4–2.1	483 (1.2)	1.1–1.3
18	36 (0.7)	0.5–0.9	96 (0.7)	0.6–0.9	125 (0.7)	0.6–0.9	45 (0.9)	0.6–1.1	302 (0.7)	0.7–0.8
31	6 (0.1)	0.0–0.2	24 (0.2)	0.1–0.3	36 (0.2)	0.1–0.3	7 (0.1)	0.0–0.2	73 (0.2)	0.1–0.2
33	33 (0.6)	0.4–0.8	73 (0.5)	0.4–0.7	128 (0.8)	0.6–0.9	61 (1.2)	0.9–1.5	295 (0.7)	0.6–0.8
35	10 (0.2)	0.1–0.3	15 (0.1)	0.1–0.2	34 (0.2)	0.1–0.3	6 (0.1)	0.0–0.2	65 (0.2)	0.1–0.2
39	25 (0.5)	0.3–0.7	78 (0.6)	0.5–0.7	84 (0.5)	0.4–0.6	24 (0.5)	0.3–0.6	211 (0.5)	0.4–0.6
45	4 (0.1)	0.0–0.2	4 (0.0)	0.0–0.1	23 (0.1)	0.1–0.2	4 (0.1)	0.0–0.2	35 (0.1)	0.1–0.1
51	20 (0.4)	0.2–0.6	63 (0.5)	0.4–0.6	74 (0.4)	0.3–0.5	26 (0.5)	0.3–0.7	183 (0.4)	0.4–0.5
52	197 (3.8)	3.3–4.3	475 (3.6)	3.2–3.9	699 (4.1)	3.8–4.4	303 (5.9)	5.2–6.5	1674 (4.1)	3.9–4.3
56	13 (0.2)	0.1–0.4	44 (0.3)	0.2–0.4	108 (0.6)	0.5–0.8	39 (0.8)	0.5–1.0	204 (0.5)	0.4–0.6
58	71 (1.4)	1.0–1.7	185 (1.4)	1.2–1.6	348 (2.1)	1.8–2.3	144 (2.8)	2.3–3.2	748 (1.8)	1.7–2.0
59	14 (0.3)	0.1–0.4	36 (0.3)	0.2–0.4	46 (0.3)	0.2–0.3	27 (0.5)	0.3–0.7	123 (0.3)	0.2–0.4
66	6 (0.1)	0.0–0.2	40 (0.3)	0.2–0.4	47 (0.3)	0.2–0.4	16 (0.3)	0.2–0.5	109 (0.3)	0.2–0.3
68	7 (0.1)	0.0–0.2	33 (0.2)	0.2–0.3	45 (0.3)	0.2–0.3	27 (0.5)	0.3–0.7	112 (0.3)	0.2–0.3

ISSN: 1471-2334